The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts
Alzheimer's & Dementia · 2025-10 · 21 (10)
DOI: 10.1002/alz.70804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 30.10.2025. Verfasst von Veerle van Gils und 37 weiteren Autor:innen. Beteiligte Einrichtung: Alzheimer Center Limburg, Mental Health and Neuroscience Research Institute, Maastricht University, Maastricht, Netherlands. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction, Diabetes Mellitus, Aging. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Community's Horizon H2020/2014 - 2020, EU/EFPIA Innovative Medicines Initiative Joint Undertaking, Alzheimer's Association.
Themen: Demenz, Diabetes mellitus
Abstract (Originalsprache)
INTRODUCTION It remains unclear whether diabetes mellitus (DM) is associated with Alzheimer's disease (AD) pathology and associated vascular burden. METHODS We included cognitively normal (CN), mild cognitive impairment (MCI), and dementia individuals. We assessed associations between DM and AD biomarkers (amyloid beta [Aβ], phosphorylated tau‐181 [p‐tau181], total tau [t‐tau], and medial temporal atrophy [MTA]) and vascular burden (white matter hyperintensities, microbleeds) by logistic regression. Secondary analyses assessed associations between DM and profiles of Aβ combined with p‐tau181/t‐tau/MTA/white matter hyperintensity/microbleeds. RESULTS We included 5550 participants (65.8+‐8.7 years, 8.7% DM). DM was associated with lower odds of abnormal AD biomarkers: Aβ in MCI (odds ratio [OR] = 0.70, 95% confidence interval [CI]: 0.51–0.95, p = 0.02) and dementia (OR = 0.44, 0.26–0.78, p = 0.003), and p‐tau181 in dementia (OR = 0.64, 0.41–1.00, p = 0.045). Secondary analyses indicated associations of DM with abnormal t‐tau (OR = 1.57, 1.00–2.46, p = 0.048) and MTA (OR = 1.96, 1.05–3.68, p = 0.04) only in CN individuals with normal Aβ. DISCUSSION In cognitively impaired individuals, DM was associated with lower odds of Aβ pathology, whereas DM was associated with neurodegeneration markers in CN individuals without Aβ pathology. Highlights Diabetes mellitus (DM) was associated with lower odds of amyloid beta (Aβ) and phosphorylated tau (p‐tau) pathology across clinical populations. DM was associated with total tau and medial temporal atrophy in cognitively normal individuals without Aβ pathology. DM may be associated with dementia through neurodegenerative pathways other than Alzheimer's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Alzheimer Center Limburg, Mental Health and Neuroscience Research Institute, Maastricht University, Maastricht, Netherlands.
- Alzheimer Center and Department of Neurology, Amsterdam Neuroscience Campus, VU University Medical Center, Amsterdam, Netherlands.
- Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
- Fundación CITA-Alzhéimer Fundazioa, Donostia, Gipuzkoa, Spain.
- Charles University, 2nd Faculty of Medicine, Motol University Hospital, Prague, Czech Republic.
- CHUV Lausanne Hospital, Lausanne, Switzerland.
ORCID-Profile: Veerle van Gils
Förderung
- European Community's Horizon H2020/2014 - 2020
- EU/EFPIA Innovative Medicines Initiative Joint Undertaking
- Alzheimer's Association
- Marie Curie International Training Network
- Innovative Medicines Initiatives
- National MS Society
- Alzheimer's Drug Discovery Foundation
- Health Holland
Zitieren
APA
van Gils, V., Jansen, W. J., van der Flier, W. M., Martinez-Lage, P., Hort, J., Ramakers, I. H. G. B., Rouaud, O., Laakso, M., Engelborghs, S., Popp, J., Lleó, A., Wallin, A., Tsolaki, M., Teunissen, C. E., Vandenberghe, R., Freund-Levi, Y., Frölich, L., Zetterberg, H., Streffer, J., …, & Vos, S. J. B. (2025). The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts. Alzheimer's & Dementia, 21(10). https://doi.org/10.1002/alz.70804
Vancouver
van Gils V, Jansen WJ, van der Flier WM, Martinez-Lage P, Hort J, Ramakers IHGB, et al. The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts. Alzheimer's & Dementia. 2025;21(10). doi:10.1002/alz.70804
BibTeX
@article{vanGils2025,
author = {van Gils, Veerle and Jansen, Willemijn J and van der Flier, Wiesje M and Martinez-Lage, Pablo and Hort, Jakub and Ramakers, Inez H G B and Rouaud, Olivier and Laakso, Markku and Engelborghs, Sebastiaan and Popp, Julius and Lleó, Alberto and Wallin, Anders and Tsolaki, Magda and Teunissen, Charlotte E and Vandenberghe, Rik and Freund-Levi, Yvonne and Frölich, Lutz and Zetterberg, Henrik and Streffer, Johannes and Lovestone, Simon and Moonen, Justine and van Harten, Argonde and Veverová, Katerina and Legdeur, Nienke and den Braber, Anouk and Damian, Daniel and Hall, Anette and Bralten, Janita and Fanelli, Giuseppe and Franke, Barbara and Poelmans, Geert and Bulló, Monica and Jimenez-Murcia, Susana and Fernandez‐Aranda, Fernando and Salas‐Salvadó, Jordi and Dalsgaard, Søren and Visser, Pieter Jelle and Vos, Stephanie J B},
title = {The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {10},
doi = {10.1002/alz.70804}
}
EUVIMED